Quaker Chemical beats Q3 sales, adjusted profit estimates

Quaker Chemical

30/10/2025 20:42

Overview

Quaker Chemical Q3 sales rose 7% yr/yr, beating analyst expectations

Adjusted EPS for Q3 beat consensus, reflecting strong operational execution

Adjusted EBITDA for Q3 exceeded analyst estimates, driven by sales growth

Outlook

Company anticipates soft market conditions to persist through year-end

Quaker Chemical expects year-over-year revenue and earnings growth in Q4

Company aims to sustain above-market growth in 2026 and beyond

Result Drivers

NEW BUSINESS WINS - Co attributes 5% of organic sales growth to new business wins globally, offsetting soft end market conditions

ASIA/PACIFIC GROWTH - Asia/Pacific segment net sales increased 18% Y/Y, driven by organic sales, acquisitions, and favorable currency impacts

ACQUISITIONS - 5% sales growth contribution from acquisitions, aiding overall revenue increase

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Beat
$493.84 mln
$475.05 mln (4 Analysts)
Q3 Adjusted EPS
Beat
$2.08
$2.01 (5 Analysts)
Q3 Adjusted Net Income
Miss
$36.27 mln
$36.60 mln (3 Analysts)
Q3 Net Income
$30.5 mln
Q3 Adjusted EBITDA
Beat
$82.85 mln
$81.26 mln (5 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the commodity chemicals peer group is "buy"

Wall Street's median 12-month price target for Quaker Chemical Corp is $160.00, about 18.5% above its October 29 closing price of $130.47

Press Release: ID:nPn4hMzq0a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)